{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:12:43Z","timestamp":1789881163996,"version":"4.0.1"},"reference-count":37,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T00:00:00Z","timestamp":1192665600000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> To test the efficacy of sulfadoxine\u2013pyremethamine (SP) monotherapy and establish the prevalence of mutations in <jats:italic>dhfr<\/jats:italic> and <jats:italic>dhps<\/jats:italic> in Brazzaville, Congo.<\/jats:p><jats:p><jats:bold>Method\u2002<\/jats:bold> We recruited 97 patients aged 6\u201359\u2003months with uncomplicated malaria who attended Tenrikyo public health centre. Eighty\u2010three were followed until day 28. SP efficacy was determined by the WHO 28\u2010day test and analysis of mutations in the <jats:italic>Plasmodium falciparum<\/jats:italic> dihydrofolate reductase (<jats:italic>pfdhfr<\/jats:italic>) and dihydropteroate synthase (<jats:italic>pfdhps<\/jats:italic>) genes.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> There were seven (8.4%) early treatment failures, 23 late treatment failures (27.7%), nine (10.8%) late parasitological failures and 44 (53%) adequate clinical and parasitological responses (ACPR). After polymerase chain reaction (PCR) analysis of 64 available samples, the corrected results there were 44 (68.8%) ACPR and 19 recrudescent cases (31.2%). Approximately, 97.5% of samples bore the Asn51Ile mutation, 66.2% the Cys59Arg mutation and 98.8% the Ser108Asn mutation. Mutations of <jats:italic>dhps<\/jats:italic> at positions 437 (Ala\u2013Gly) and 436 (Ser\u2013Ala) were found in 85% and 12.5% of samples. Quadruple mutations (<jats:italic>pfdhfr<\/jats:italic> triple mutations in codons 51, 59 and 108+ <jats:italic>pfdhps<\/jats:italic> mutation in 437) were found in 42 samples (52.5%) and associated with treatment failures.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> This high level of treatment failures and mutations in both genes calls for the urgent application of the new policy for malaria treatment to delay the spread of SP resistance.<\/jats:p>","DOI":"10.1111\/j.1365-3156.2007.01904.x","type":"journal-article","created":{"date-parts":[[2010,8,11]],"date-time":"2010-08-11T22:05:41Z","timestamp":1281564341000},"page":"1164-1171","source":"Crossref","is-referenced-by-count":28,"title":["Therapeutic efficacy of sulfadoxine\u2013pyrimethamine and the prevalence of molecular markers of resistance in under 5\u2010year olds in Brazzaville, Congo"],"prefix":"10.1111","volume":"12","author":[{"given":"Mathieu","family":"Ndounga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachida","family":"Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo K.","family":"Basco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisca N.","family":"Casimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Malonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4269\/ajtmh.2003.69.601","article-title":"Prediction of Plasmodium falciparum resistance to sulfadoxine\/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity","volume":"69","author":"Alifrangis M","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/315731"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4269\/ajtmh.2004.70.238","article-title":"Molecular epidemiology of malaria in Cameroon. XVIII. Polymorphisms of Plasmodium falciparum merozoite surface antigene\u20102 in isolates from symptomatic patients","volume":"70","author":"Basco LK","year":"2004","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_5_1","first-page":"17","article-title":"Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum","volume":"50","author":"Biswas S","year":"2004","journal-title":"Journal of Postgraduate Medicine"},{"key":"e_1_2_6_6_1","first-page":"55","article-title":"Widespread in vitro resistance to chloroquine of Plasmodium falciparum in the Congo, 1987","volume":"42","author":"Brandicourt O","year":"1991","journal-title":"Tropical Medicine and Parasitology"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-706X(02)00264-4"},{"key":"e_1_2_6_8_1","first-page":"228","article-title":"La chimior\u00e9sistance m\u00e9dicamenteuse de Plasmodium falciparum au Congo. Bilan des enqu\u00eates r\u00e9alis\u00e9es de 1985 \u00e0 1989","volume":"83","author":"Carme B","year":"1990","journal-title":"Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91158-Q"},{"key":"e_1_2_6_10_1","first-page":"164","article-title":"Niveau de chloroquinor\u00e9sistance inchang\u00e9(Plasmodium falciparum) chez l\u2019enfant semi\u2010immun depuis 1986 \u00e0 Brazzaville","volume":"91","author":"Carme B","year":"1998","journal-title":"Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique"},{"key":"e_1_2_6_11_1","first-page":"25","article-title":"Chimiosensibilit\u00e9in vivo et in vitro de Plasmodium falciparum\u00e0 Brazzaville (Congo)","volume":"5","author":"Chandenier J","year":"1995","journal-title":"Cahiers d\u2019\u00e9tudes et de recherches francophones\/Sant\u00e9"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4269\/ajtmh.2006.75.152","article-title":"Molecular markers associated with Plasmodium falciparum resistance to sulfadoxine\u2013pyrimethamine in the Democratic Republic of Congo","volume":"75","author":"Cohuet S","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-5-49"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1086\/517831"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.2003.01098.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)24022-0"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/338566"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4269\/ajtmh.2003.69.247","article-title":"Validation of a simplified method for using molecular markers to predict sulfadoxine\u2013pyrimethamine treatment failure in African children with falciparum malaria","volume":"69","author":"Kyabayinze D","year":"2003","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_19_1","first-page":"200","article-title":"Pr\u00e9valence du paludisme \u00e0 l\u2019accouchement dans quatre maternit\u00e9s de la ville de Kinshasa, R\u00e9publique D\u00e9mocratique du Congo","volume":"99","author":"Lukuka KA","year":"2006","journal-title":"Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.2006.74.205","article-title":"Frequency distribution of antimalarial drug\u2010resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic","volume":"74","author":"Menard D","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf030"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01471.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2004.70.133","article-title":"Efficacy of sulfadoxine\/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo","volume":"70","author":"Nsimba B","year":"2004","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01490.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/514159"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2001083243"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762005000400019"},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4269\/ajtmh.2006.75.396","article-title":"Molecular epidemiology of malaria in Cameroon. XXIII. Geographic mapping and distribution of Plasmodium falciparum dihydrofolate reductase (dhfr) mutant alleles","volume":"75","author":"Tahar R","year":"2006","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2004.04.002"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(02)90385-8"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(87)90472-X"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.25.13944"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(97)00114-X"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020003"},{"key":"e_1_2_6_35_1","volume-title":"Chemotherapy of Malaria and Resistance to Antimalarials","author":"World Heath Organization","year":"1973"},{"key":"e_1_2_6_36_1","volume-title":"Assessment of Therapeutic Efficacy for Uncomplicated falciparum Malaria in Areas With Intense Transmission","author":"World Heath Organization","year":"1996"},{"key":"e_1_2_6_37_1","volume-title":"Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria","author":"World Heath Organization","year":"2003"},{"key":"e_1_2_6_38_1","volume-title":"Guidelines for the Treatment of Malaria","author":"World Heath Organization","year":"2006"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3156.2007.01904.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3156.2007.01904.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T20:47:24Z","timestamp":1696884444000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3156.2007.01904.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1365-3156.2007.01904.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3156.2007.01904.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}